litlas
Log inCreate account

Wim Robberecht

Active 1989–2024

131
Papers
27,482
Citations
94
h-index
129
i10-index

Citations

Citations per year for Wim Robberecht1951: 3 citations1967: 2 citations1989: 1 citations1990: 1 citations1991: 1 citations1992: 1 citations1993: 2 citations1994: 6 citations1995: 14 citations1996: 11 citations1997: 16 citations1998: 6 citations1999: 10 citations2000: 30 citations2001: 25 citations2002: 76 citations2003: 85 citations2004: 161 citations2005: 175 citations2006: 183 citations2007: 193 citations2008: 220 citations2009: 299 citations2010: 294 citations2011: 329 citations2012: 332 citations2013: 355 citations2014: 352 citations2015: 291 citations2016: 340 citations2017: 387 citations2018: 341 citations2019: 1,042 citations2020: 1,247 citations2021: 1,155 citations2022: 773 citations2023: 602 citations2024: 787 citations2025: 380 citations2026: 12 citations1952–1966: no citations, so these years are not shown1968–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,926 citing papers, 24.9% of this breakdownUnited Kingdom: 1,036 citing papers, 8.8% of this breakdownItaly: 819 citing papers, 7% of this breakdownGermany: 801 citing papers, 6.8% of this breakdownChina: 667 citing papers, 5.7% of this breakdownCanada: 516 citing papers, 4.4% of this breakdownBelgium: 478 citing papers, 4.1% of this breakdownFrance: 445 citing papers, 3.8% of this breakdownNetherlands: 441 citing papers, 3.7% of this breakdownAustralia: 408 citing papers, 3.5% of this breakdownJapan: 333 citing papers, 2.8% of this breakdownSpain: 286 citing papers, 2.4% of this breakdown
0%24.9%Other 22.1%

Institutions

Fields

  • Medicine59.4%
  • Biochemistry, Genetics and Molecular Biology25.2%
  • Neuroscience12.4%
  • Immunology and Microbiology0.8%
  • Nursing0.4%
  • Computer Science0.4%
  • Other1.4%

Topics

  • Amyotrophic Lateral Sclerosis Research16.6%
  • Neurogenetic and Muscular Disorders Research8.4%
  • Parkinson's Disease Mechanisms and Treatments4.1%
  • Alzheimer's disease research and treatments3.7%
  • Genetic Neurodegenerative Diseases3.7%
  • RNA Research and Splicing3.6%
  • Other59.9%

Coauthors

All papers

Open in search
  1. Amyotrophic lateral sclerosis

    Authors: Orla Hardiman, Ammar Al‐Chalabi, Adriano Chiò, Emma M. Corr, Giancarlo Logroscino, Wim Robberecht, Pamela J. Shaw, Zachary Simmons, Leonard H. van den Berg - Nature Reviews Disease Primers 2017 cited by 1,382

  2. The phenotypic variability of amyotrophic lateral sclerosis

    Authors: Bart Swinnen, Wim Robberecht - Nature Reviews Neurology 2014 cited by 595

  3. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients

    Authors: Wenting Guo, Maximilian Naujock, Laura Fumagalli, Tijs Vandoorne, Pieter Baatsen, Ruben Boon, Laura Ordovás, Abdulsamie Patel, Marie Welters, Thomas Vanwelden, Natasja Geens, Tine Tricot, Veronick Benoy, Jolien Steyaert, Cynthia Lefebvre-Omar, Werend Boesmans, Matthew Jarpe, Jared Sterneckert, Florian Wegner, Susanne Petri, Delphine Bohl, Pieter Vanden Berghe, Wim Robberecht, Philip Van Damme, Catherine M. Verfaillie, Ludo Van Den Bosch - Nature Communications 2017 cited by 380

  4. Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics

    Authors: Steven Boeynaems, Elke Bogaert, Dénes Kovács, Albert Konijnenberg, Evy Timmerman, Alexander N. Volkov, Mainak Guharoy, Mathias De Decker, Tom Jaspers, Veronica H. Ryan, Abigail M. Janke, Pieter Baatsen, Thomas Vercruysse, Regina‐Maria Kolaitis, Dirk Daelemans, J. Paul Taylor, Nancy Kedersha, Paul Anderson, Francis Impens, Frank Sobott, Joost Schymkowitz, Frédéric Rousseau, Nicolas L. Fawzi, Wim Robberecht, Philip Van Damme, Péter Tompa, Ludo Van Den Bosch - Molecular Cell 2017 cited by 545

  5. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

    Authors: Thomas Philips, Wim Robberecht - The Lancet Neurology 2011 cited by 639

  6. The changing scene of amyotrophic lateral sclerosis

    Authors: Wim Robberecht, Thomas Philips - Nature reviews. Neuroscience 2013 cited by 963

  7. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis

    Authors: Sai Zhang, Johnathan Cooper‐Knock, Annika K. Weimer, Minyi Shi, Tobias Moll, Jack N.G. Marshall, Calum Harvey, Helia Ghahremani Nezhad, John Franklin, Cleide Dos Santos Souza, Ke Ning, Cheng Wang, Jingjing Li, Allison A. Dilliott, Sali M.K. Farhan, Eran Elhaik, Iris-Stefania Pasniceanu, Matthew R. Livesey, Chen Eitan, Eran Hornstein, Kevin P. Kenna, Ian P. Blair, Naomi R. Wray, Matthew C. Kiernan, Miguel Mitne‐Neto, Adriano Chiò, Ruben J. Cauchi, Wim Robberecht, Philip Van Damme, Philippe Corcia, Philippe Couratier, Orla Hardiman, Russell McLaughin, Marc Gotkine, Vivian E. Drory, Nicola Ticozzi, Vincenzo Silani, Jan H. Veldink, Leonard H. van den Berg, Mamede de Carvalho, Jesús S. Mora Pardina, Mónica Povedano, Peter M. Andersen, Markus Weber, Nazlı Başak, Ammar Al‐Chalabi, Christopher E. Shaw, Pamela J. Shaw, Karen Morrison, John E. Landers, Jonathan D. Glass, Jan H. Veldink, Laura Ferraiuolo, Pamela J. Shaw, M Snyder - Neuron 2022 cited by 122

  8. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis

    Authors: Ludo Van Den Bosch, Philip Van Damme, Elke Bogaert, Wim Robberecht - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2006 cited by 482

  9. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS

    Authors: Ana Jovičić, Jérôme Mertens, Steven Boeynaems, Elke Bogaert, Noori Chai, Shizuka Yamada, Joseph W. Paul, Shuying Sun, Joseph R. Herdy, Gregor Bieri, Nicholas J. Kramer, Fred H. Gage, Ludo Van Den Bosch, Wim Robberecht, Aaron D. Gitler - Nature Neuroscience 2015 cited by 636

  10. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease

    Authors: Constantin d’Ydewalle, Jyothsna Krishnan, Driss M Chiheb, Philip Van Damme, Joy Irobi, Alan P. Kozikowski, Pieter Vanden Berghe, Vincent Timmerman, Wim Robberecht, Ludo Van Den Bosch - Nature Medicine 2011 cited by 461

  11. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Authors: Kevin P. Kenna, Perry T.C. van Doormaal, Annelot M. Dekker, Nicola Ticozzi, Brendan Kenna, Frank P. Diekstra, Wouter van Rheenen, Kristel R. van Eijk, Ashley R Jones, Pamela Keagle, Aleksey Shatunov, William Sproviero, Bradley Smith, Michael A. van Es, Simon Topp, Aoife Kenna, Jack W. Miller, Claudia Fallini, Cinzia Tiloca, Russell L. McLaughlin, Caroline Vance, Claire Troakes, Claudia Colombrita, Gabriele Mora, Andrea Calvo, Federico Verde, Safa Al‐Sarraj, Andrew King, Daniela Calini, Jacqueline de Belleroche, Frank Baas, Anneke J. van der Kooi, Marianne de Visser, Anneloor L.M.A. ten Asbroek, Peter C. Sapp, Diane McKenna‐Yasek, Meraida Polak, Seneshaw Asress, José Luís Muñoz-Blanco, Tim M. Strom, Thomas Meitinger, Karen Morrison, Giuseppe Lauria, Kelly L. Williams, P. Nigel Leigh, Garth A. Nicholson, Ian P. Blair, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Khrista Boylan, Marka van Blitterswijk, Rosa Rademakers, Jesús Esteban‐Pérez, Alberto García‐Redondo, Phillip Van Damme, Wim Robberecht, Adriano Chiò, Cinzia Gellera, Carsten Drepper, Michael Sendtner, Antonia Ratti, Jonathan D. Glass, Jesús S. Mora, Nazlı Başak, Orla Hardiman, Albert C. Ludolph, Peter M. Andersen, Jochen H. Weishaupt, Robert H. Brown, Ammar Al‐Chalabi, Vincenzo Silani, Christopher E. Shaw, Leonard H. van den Berg, Jan H. Veldink, John E. Landers - Nature Genetics 2016 cited by 294

  12. A revision of the El Escorial criteria - 2015

    Authors: Albert C. Ludolph, Vivian E. Drory, Orla Hardiman, Imaharu Nakano, John Ravits, Wim Robberecht, Jeremy M. Shefner, for The WFN Research Group On ALS/MND - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2015 cited by 478

  13. Correction: Amyotrophic lateral sclerosis

    Authors: Orla Hardiman, Ammar Al‐Chalabi, Adriano Chiò, Emma M. Corr, Giancarlo Logroscino, Wim Robberecht, Pamela J. Shaw, Zachary Simmons, Leonard H. van den Berg - Nature Reviews Disease Primers 2017 cited by 359

  14. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis

    Authors: Thomas Philips, André Bento‐Abreu, Annelies Nonneman, Wanda Haeck, Kim A. Staats, Veerle Geelen, Nicole Hersmus, Benno Küsters, Ludo Van Den Bosch, Philip Van Damme, William D. Richardson, Wim Robberecht - Brain 2013 cited by 250

  15. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis

    Authors: Wouter Van Rheenen, Sara L. Pulit, Annelot M. Dekker, William J. Brands, Bas Middelkoop, Raymond D. Schellevis, Gijs H. P. Tazelaar, Rick A. A. Van der Spek, Perry T. C. Van Doormaal, Kristel R. Van Eijk, Joke Van Vugt, Michael A. Van Es, Leonard H. Van den Berg, Jan H. Veldink, Ahmad Al Khleifat, Aleksey Shatunov, William Sproviero, Christopher E. Shaw, Ammar Al-Chalabi, Alfredo Iacoangeli, Stephen Newhouse, Kevin P. Kenna, John E. Landers, Ersen Kavak, Maarten Kooyman, Russell L. McLaughlin, Matthieu Moisse, Wim Robberecht, Philip Van Damme, A. Nazli Basak, Ian P. Blair, Jonathan D. Glass, Orla Hardiman, Winston Hide, Pamela J. Shaw, Jesus S. Mora, Karen E. Morrison, Naomi R. Wray - European Journal of Human Genetics 2018 cited by 198

  16. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

    Authors: Michael A. van Es, Jan H. Veldink, Christiaan G. J. Saris, Hylke M. Blauw, Paul W.J. van Vught, Anna Birve, Robin Lemmens, Helenius J. Schelhaas, Ewout J. N. Groen, Mark Huisman, Anneke J. van der Kooi, Marianne de Visser, Caroline Dahlberg, Karol Estrada, Fernando Rivadeneira, Albert Hofman, Machiel J. Zwarts, Perry T.C. van Doormaal, Dan Rujescu, Eric Strengman, Ina Giegling, Pierandrea Muglia, Barbara Tomik, Agnieszka Słowik, André G. Uitterlinden, Corinna Hendrich, Stefan Waibel, Thomas Meyer, Albert C. Ludolph, Jonathan D. Glass, Shaun Purcell, Sven Cichon, Markus M. Nöthen, H‐Erich Wichmann, Stefan Schreiber, Sita H. Vermeulen, Lambertus A. Kiemeney, John H. J. Wokke, Simon Cronin, Russell L. McLaughlin, Orla Hardiman, Katsumi Fumoto, R. Jeroen Pasterkamp, Vincent Meininger, Judith Melki, P. Nigel Leigh, Christopher E. Shaw, John E. Landers, Ammar Al‐Chalabi, Robert H. Brown, Wim Robberecht, Peter M. Andersen, Roel A. Ophoff, Leonard H. van den Berg - Nature Genetics 2009 cited by 404

  17. RNA toxicity in non‐coding repeat expansion disorders

    Authors: Bart Swinnen, Wim Robberecht, Ludo Van Den Bosch - The EMBO Journal 2019 cited by 169

  18. Modelling amyotrophic lateral sclerosis: progress and possibilities

    Authors: Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch - Disease Models & Mechanisms 2017 cited by 199

  19. ATXN2 trinucleotide repeat length correlates with risk of ALS

    Authors: William Sproviero, Aleksey Shatunov, Daniel Ståhl, Maryam Shoai, Wouter van Rheenen, Ashley R. Jones, Safa Al‐Sarraj, Peter M. Andersen, Nancy M. Bonini, F. L. Conforti, Philip Van Damme, Hussein Daoud, Maria del Mar Amador, Isabella Fogh, Monica Forzan, Ben Gaastra, Cinzia Gellera, Aaron D. Gitler, John Hardy, Pietro Fratta, Vincenzo La Bella, Isabelle Le Ber, Tim Van Langenhove, Serena Lattante, Yi‐Chung Lee, Andrea Malaspina, Vincent Meininger, Stéphanie Millecamps, Richard W. Orrell, Rosa Rademakers, Wim Robberecht, Guy A. Rouleau, Owen A. Ross, François Salachas, Katie Sidle, Bradley Smith, Bing‐Wen Soong, Gianni Sorarú, Giovanni Stévanin, Edor Kabashi, Claire Troakes, Christine Van Broeckhoven, Jan H. Veldink, Leonard H. van den Berg, Christopher E. Shaw, John Powell, Ammar Al‐Chalabi - Neurobiology of Aging 2016 cited by 130

  20. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease

    Authors: Veronick Benoy, Lawrence Van Helleputte, Robert Prior, Constantin d’Ydewalle, Wanda Haeck, Natasja Geens, Wendy Scheveneels, Begga Schevenels, M. Zameel Cader, Kevin Talbot, Alan P. Kozikowski, Pieter Vanden Berghe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch - Brain 2017 cited by 122

  21. The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

    Authors: Sarah Opie-Martin, Alfredo Iacoangeli, Simon Topp, Olubunmi Abel, Keith Mayl, Puja R. Mehta, Aleksey Shatunov, Isabella Fogh, Harry Bowles, Naomi Limbachiya, Thomas P Spargo, Ahmad Al Khleifat, Kelly L. Williams, Jennifer Jockel‐Balsarotti, Taha Bali, Wade Self, Lyndal Henden, Garth A. Nicholson, Nicola Ticozzi, Diane McKenna‐Yasek, Lu Tang, Pamela J. Shaw, Adriano Chiò, Albert Ludolph, Jochen H. Weishaupt, John E. Landers, Jonathan D. Glass, Jesús S. Mora, Wim Robberecht, Philip Van Damme, Russell L. McLaughlin, Orla Hardiman, Leonard van den Berg, Jan H. Veldink, Phillippe Corcia, Zorica Stević, Nailah Siddique, Vincenzo Silani, Ian P. Blair, Dongsheng Fan, Florence Esselin, Elisa De La Cruz, William Camu, Nazlı Başak, Teepu Siddique, Jonathan Mill, Robert H. Brown, Ammar Al‐Chalabi, Christopher E. Shaw - Nature Communications 2022 cited by 56

  22. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study

    Authors: Ilse Gijselinck, Tim Van Langenhove, Julie van der Zee, Kristel Sleegers, Stéphanie Philtjens, Gernot Kleinberger, Jonathan Janssens, Karolien Bettens, Caroline Van Cauwenberghe, Sandra Pereson, Sebastiaan Engelborghs, Anne Sieben, Peter De Jonghe, Rik Vandenberghe, Patrick Santens, Jan De Bleecker, Githa Maes, Veerle Bäumer, Lubina Dillen, Geert Joris, Ivy Cuijt, Ellen Corsmit, Ellen Elinck, Jasper Van Dongen, Steven Vermeulen, Marleen Van den Broeck, C Vaerenberg, Maria Mattheijssens, Karin Peeters, Wim Robberecht, Patrick Cras, Jean‐Jacques Martin, Peter P. De Deyn, Marc Cruts, Christine Van Broeckhoven - The Lancet Neurology 2011 cited by 628

  23. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival

    Authors: Philip Van Damme, Annelies Van Hoecke, Diether Lambrechts, Peter Vanacker, Elke Bogaert, John C. van Swieten, Peter Carmeliet, Ludo Van Den Bosch, Wim Robberecht - The Journal of Cell Biology 2008 cited by 418

  24. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy

    Authors: Albena Jordanova, Joy Irobi, Florian P. Thomas, Patrick Van Dijck, Kris Meerschaert, Maarten Dewil, Ines Dierick, An Jacobs, Els De Vriendt, Velina Guergueltcheva, Chitharanjan V. Rao, Ivailo Tournev, Francisco A A Gondim, Marc D’Hooghe, Veerle Van Gerwen, Patrick Callaerts, Ludo Van Den Bosch, Jean‐Pierre Timmermans, Wim Robberecht, Jan Gettemans, Johan M. Thevelein, Peter De Jonghe, Ivo Kremensky, Vincent Timmerman - Nature Genetics 2006 cited by 376